139 related articles for article (PubMed ID: 22661763)
41. 21st Century Evidence: Randomized Controlled Trials Versus Systematic Reviews and Meta-Analyses.
Agarwal A; Rochwerg B; Sevransky JE
Crit Care Med; 2021 Dec; 49(12):2001-2002. PubMed ID: 34582418
[No Abstract] [Full Text] [Related]
42. RCTs of ergonomic interventions.
Westgaard RH
Occup Environ Med; 2010 Apr; 67(4):217-8. PubMed ID: 20360193
[No Abstract] [Full Text] [Related]
43. Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses.
Schandelmaier S; Briel M; Varadhan R; Schmid CH; Devasenapathy N; Hayward RA; Gagnier J; Borenstein M; van der Heijden GJMG; Dahabreh IJ; Sun X; Sauerbrei W; Walsh M; Ioannidis JPA; Thabane L; Guyatt GH
CMAJ; 2020 Aug; 192(32):E901-E906. PubMed ID: 32778601
[TBL] [Abstract][Full Text] [Related]
44. Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies.
Hahn S; Williamson PR; Hutton JL; Garner P; Flynn EV
Stat Med; 2000 Dec; 19(24):3325-36. PubMed ID: 11122498
[TBL] [Abstract][Full Text] [Related]
45. Generalizing from clinical trial data: a case study. The risk of suicidality among pediatric antidepressant users.
Greenhouse JB; Kaizar EE; Kelleher K; Seltman H; Gardner W
Stat Med; 2008 May; 27(11):1801-13. PubMed ID: 18381709
[TBL] [Abstract][Full Text] [Related]
46. Prespecification of subgroup analyses and examination of treatment-subgroup interactions in cancer individual participant data meta-analyses are suboptimal.
Gao Y; Liu M; Shi S; Niu M; Li J; Zhang J; Song F; Tian J
J Clin Epidemiol; 2021 Oct; 138():156-167. PubMed ID: 34186194
[TBL] [Abstract][Full Text] [Related]
47. An empirical study using permutation-based resampling in meta-regression.
Gagnier JJ; Moher D; Boon H; Bombardier C; Beyene J
Syst Rev; 2012 Feb; 1():18. PubMed ID: 22587815
[TBL] [Abstract][Full Text] [Related]
48. Authors' response: RCTs of ergonomic interventions.
Driessen MT; Anema JR; Proper KI; van der Beek AJ
Occup Environ Med; 2010 Apr; 67(4):218-9. PubMed ID: 20360194
[No Abstract] [Full Text] [Related]
49. Meta-analysis in the assessment of treatment outcome.
Geddes J
J Psychopharmacol; 2006 Jul; 20(4 Suppl):67-71. PubMed ID: 16785273
[TBL] [Abstract][Full Text] [Related]
50. A systematic review of individual patient data meta-analyses on surgical interventions.
Hannink G; Gooszen HG; van Laarhoven CJ; Rovers MM
Syst Rev; 2013 Jul; 2():52. PubMed ID: 23826895
[TBL] [Abstract][Full Text] [Related]
51. Value and limitation of meta-analysis.
Verstraete M
Pathophysiol Haemost Thromb; 2002; 32(5-6):278-81. PubMed ID: 13679657
[TBL] [Abstract][Full Text] [Related]
52. The lack of statistical power of subgroup analyses in meta-analyses: a cautionary note.
Cuijpers P; Griffin JW; Furukawa TA
Epidemiol Psychiatr Sci; 2021 Dec; 30():e78. PubMed ID: 34852862
[TBL] [Abstract][Full Text] [Related]
53. Evidence from randomized controlled trials, meta-analyses, and subgroup analyses.
Bolland MJ; Grey A; Reid IR
JAMA; 2010 Apr; 303(13):1254; author reply 1254-5. PubMed ID: 20371782
[No Abstract] [Full Text] [Related]
54. Interpretation of subgroup analyses in randomized trials: heterogeneity versus secondary interventions.
VanderWeele TJ; Knol MJ
Ann Intern Med; 2011 May; 154(10):680-3. PubMed ID: 21576536
[TBL] [Abstract][Full Text] [Related]
55. Pediatric literature shift: Growth of meta-analyses was 23 times greater than growth of randomized trials.
Niforatos JD; Chaitoff A; Weaver M; Feinstein MM; Johansen ME
J Clin Epidemiol; 2020 May; 121():112-114. PubMed ID: 32004671
[No Abstract] [Full Text] [Related]
56. Discrepancies among megatrials.
Furukawa TA; Streiner DL; Hori S
J Clin Epidemiol; 2000 Dec; 53(12):1193-9. PubMed ID: 11146264
[TBL] [Abstract][Full Text] [Related]
57. Evidence from randomized controlled trials, meta-analyses, and subgroup analyses.
Vosk A
JAMA; 2010 Apr; 303(13):1253; author reply 1254-5. PubMed ID: 20371781
[No Abstract] [Full Text] [Related]
58. The evaluation of different approaches to randomized clinical trials. Report on the 1987 MacArthur Foundation Network I Methodology Workshop.
Kraemer HC; Pruyn JP
Arch Gen Psychiatry; 1990 Dec; 47(12):1163-9. PubMed ID: 2147099
[TBL] [Abstract][Full Text] [Related]
59. Biostatistics primer: what a clinician ought to know: subgroup analyses.
Barraclough H; Govindan R
J Thorac Oncol; 2010 May; 5(5):741-6. PubMed ID: 20421767
[TBL] [Abstract][Full Text] [Related]
60. A consumer's guide to subgroup analyses.
Oxman AD; Guyatt GH
Ann Intern Med; 1992 Jan; 116(1):78-84. PubMed ID: 1530753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
